Advertisement

Pediatric Nephrology

, Volume 20, Issue 6, pp 824–827 | Cite as

Clinico-pathologic findings in medullary cystic kidney disease type 2

  • Anthony J. BleyerEmail author
  • Thomas C. Hart
  • Mark C. Willingham
  • Samy S. Iskandar
  • Michael C. Gorry
  • Howard Trachtman
Brief Report

Abstract

Medullary cystic kidney disease type 2 is an uncommon autosomal dominant condition characterized by juvenile onset hyperuricemia, precocious gout and chronic renal failure progressing to end-stage renal disease in the 4th through 7th decades of life. A family suffering from this condition is described. The patient in the index case presented with renal insufficiency as a child. A renal biopsy revealed tubular atrophy, and immunohistochemical staining of the tissue for uromodulin (Tamm Horsfall protein) revealed dense deposits in renal tubular cells. Genetic testing revealed a single nucleotide mutation (c.899G>A) resulting in an exchange of a cysteine residue for tyrosine (C300Y). Medullary cystic kidney disease type 2 (also known as uromodulin-associated kidney disease) likely represents a form of endoplasmic reticulum storage disease, with deposition of the abnormal uromodulin protein in the endoplasmic reticulum, leading to tubular cell atrophy and death.

Keywords

Uromodulin-associated kidney disease Familial juvenile hyperuricemic nephropathy Tamm Horsfall protein Uromodulin 

Notes

Acknowledgements

This grant was supported in part by United States Public Health Service research grant DK62252 from the National Institute of Diabetes and Digestive and Kidney Diseases and by a grant from the National Kidney Foundation of North Carolina, Inc. The authors wish to thank Vicki Robins, R.N., and Rachel Frank, R.N., C.N.N., for their assistance with this manuscript. Antibody to Tamm Horsfall protein was kindly provided by John Hoyer, M.D., Children’s Hospital of Philadelphia, Philadelphia, PA. Three of the authors (AJB, TCH and MCG) and their institutions have entered a licensing agreement with Athena Diagnostics, Inc., for uromodulin mutational analysis.

References

  1. 1.
    Bleyer AJ, Woodard AS, Shihabi ZK, Sandhu J, Zhu H, Satko SG, Weller N, Deterding E, McBride D, Gorry MC, Xu L, Ganier D, Hart TC (2003) Clinical characterization of a family with a mutation in the uromodulin (Tamm-Horsfall glycoprotein) gene. Kidney Int 64:36–42Google Scholar
  2. 2.
    Hart TC, Gorry MC, Hart PS, Woodard AS, Shihabi Z, Sandhu J, Shirts B, Xu L, Zhu H, Barmada MM, Bleyer AJ (2002) Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet 39:882–892Google Scholar
  3. 3.
    Wolf MTF, Mucha BE, Attanasio M, Zalewski I, Karle SM, Neumann HP, Rahman N, Bader B, Baldamus CA, Otto E, Witzgall R, Fuchshuber A, Hildebrandt F (2003) Mutations in the uromodulin gene in MCKD type 2 patients cluster in exon 4, which encodes three EGF-like domains. Kidney Int 64:1580–1587Google Scholar
  4. 4.
    Serafini-Cessi F, Malagolini N, Cavallone D (2003) Tamm-Horsfall glycoprotein: biology and clinical relevance. Am J Kidney Dis 42:658–676Google Scholar
  5. 5.
    Mo L, Zhu XH, Huang HY, Shapiro E, Hasty DL, Wu XR (2004) Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli. Am J Physiol Renal Physiol 286:F795–802Google Scholar
  6. 6.
    Cameron JS, Moro F, Simmonds HA (1993) Gout, uric and purine metabolism in pediatric nephrology. Pediatr Nephrol 7:105–118Google Scholar
  7. 7.
    Bleyer AJ, Trachtman H, Sandhu J, Gorry MC, Hart TC (2003) Renal manifestations of a mutation in the uromodulin (Tamm Horsfall protein) gene. Am J Kidney Dis 42:1–7Google Scholar
  8. 8.
    Hoyer JR, Resnick JS, Michael AF, Vernier RL (1974) Ontogeny of Tamm-Horsfall urinary glycoprotein. Lab Invest 30:757–761Google Scholar
  9. 9.
    Neumann HPH, Zauner I, Strahm B, Bender BU, Schollmeyer P, Blum U, Rohrbach R, Hildebrandt F (1997) Late occurrence of cysts in autosomal dominant medullary cystic kidney disease. Nephrol Dial Transplant 12:1242–1246Google Scholar
  10. 10.
    Turner JJO, Stacey JM, Harding B, Kotanko P, Lhotta K, Puig JG, Roberts I, Torres RJ, Thakker RV (2003) Uromodulin mutations cause familial juvenile hyperuricemic nephropathy. J Clin Endocrin Metab 88:1398–1401Google Scholar
  11. 11.
    Rampoldi L, Caridi G, Santon D, Boaretto F, Bernascone I, Lamore G, Tardanico R, Dagnino M, Colussi G, Scolari F, Ghiggeri GM, Amoroso A, Casari G (2003) Allelism of MCKD, FJHN, and GCKD caused by impairment of uromodulin export dynamics. Hum Mol Genet 12:3369–3384Google Scholar
  12. 12.
    Dahan K, Devuyst O, Smaers M, Vertommen D, Loute G, Poux JM, Viron B, Jacquot C, Gagnadoux MF, Chauveau D, Buchler M, Cochat P, Cosyns JP, Mougenot B, Rider MH, Antignac C, Verellen-Dumoulin C, Pirson Y (2003) A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin. J Am Soc Nephrol 14:2883–2893Google Scholar
  13. 13.
    Rutishauser J, Spiess M (2002) Endoplasmic reticulum storage diseases. Swiss Med Wkly 132:211–222Google Scholar

Copyright information

© IPNA 2005

Authors and Affiliations

  • Anthony J. Bleyer
    • 1
    Email author
  • Thomas C. Hart
    • 2
  • Mark C. Willingham
    • 3
  • Samy S. Iskandar
    • 3
  • Michael C. Gorry
    • 4
  • Howard Trachtman
    • 5
  1. 1.Section on NephrologyWake Forest University School of MedicineWinston-SalemUSA
  2. 2.National Institute of Dental and Cranio-Facial ResearchNational Institutes of HealthBethesdaUSA
  3. 3.Department of PathologyWake Forest University School of MedicineWinston-SalemUSA
  4. 4.Division of Oral BiologyUniversity of Pittsburgh School of Dental MedicinePittsburghUSA
  5. 5.Division of NephrologySchneider Children’s HospitalNew Hyde ParkUSA

Personalised recommendations